PRWDF (PT Prodia Widyahusada Tbk) Cash Payments: $-112.06 Mil (TTM As of Mar. 2026)


What is PT Prodia Widyahusada Tbk Cash Payments?

PT Prodia Widyahusada Tbk PRWDF 69 Cash Payments is $-112.06 Mil as of Mar. 2026. GuruFocus rates PRWDF with a GF Score™ of 69/100. The stock has 2 warning signs investors should review.

PT Prodia Widyahusada Tbk's Cash Payments for the three months ended in Mar. 2026 was $-26.43 Mil.

PT Prodia Widyahusada Tbk's Cash Payments for the trailing twelve months (TTM) ended in Mar. 2026 was $-112.06 Mil.

PT Prodia Widyahusada Tbk Cash Payments Historical Data

* Premium members only.

The historical data trend for PT Prodia Widyahusada Tbk's Cash Payments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Prodia Widyahusada Tbk Cash Payments Chart

PT Prodia Widyahusada Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Payments
Get a 7-Day Free Trial Premium Member Only Premium Member Only -121.19 -103.70 -111.06 -108.94 -109.75

PT Prodia Widyahusada Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Payments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.46 -27.82 -26.45 -31.37 -26.43

PT Prodia Widyahusada Tbk Cash Payments Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Payments represents cash flow paid from operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Payments" section for non-financial companies:
Payments to Suppliers for Goods and Services
Payments on Behalf of Employees
Other Cash Payments from Operating Activities

Cash Payments for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-112.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Payments →
What does a Cash Payments of $-112.06 Mil mean?
PT Prodia Widyahusada Tbk (PRWDF) has a Cash Payments of $-112.06 Mil as of Mar. 2026. Cash Payments represents cash paid from operating activities in direct cash flow method. View historical data for PT Prodia Widyahusada Tbk and its competitors.
Is PT Prodia Widyahusada Tbk's Cash Payments too high?
PT Prodia Widyahusada Tbk's current Cash Payments is $-112.06 Mil. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Cash Payments compare to TMO and DHR?
PT Prodia Widyahusada Tbk's Cash Payments of $-112.06 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Payments for a Medical Diagnostics & Research company?
A good Cash Payments depends on the Medical Diagnostics & Research industry context. However, Cash Payments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Payments mean?
A high Cash Payments can signal that a stock is expensive relative to its fundamentals. Cash Payments represents cash paid from operating activities in direct cash flow method. View historical data for PT Prodia Widyahusada Tbk and its competitors. PT Prodia Widyahusada Tbk's current Cash Payments is $-112.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current Cash Payments of $-112.06 Mil. The current Cash Payments is $-112.06 Mil. PT Prodia Widyahusada Tbk's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Payments calculated?
Cash Payments is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current Cash Payments is $-112.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Prodia Widyahusada Tbk Business Description

Other Exchanges PRDA:Indonesia
Address Jl. Kramat Raya No.150, Prodia Tower, Pusat, Jakarta, IDN, 10430
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.